Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
ClinicalTrials.gov study NCT02203825. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
ClinicalTrials.gov study NCT02783625. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.
ClinicalTrials.gov study NCT06474169. IPD Sharing: NO. Countries: 1. Publications: 7.
Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
ClinicalTrials.gov study NCT04703686. IPD Sharing: NO. Countries: 1. Publications: 0.
High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressiv
ClinicalTrials.gov study NCT01840566. IPD Sharing: Not stated. Countries: 1. Publications: 2.
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome
ClinicalTrials.gov study NCT06588491. IPD Sharing: NO. Countries: 1. Publications: 2.
KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
ClinicalTrials.gov study NCT06400303. IPD Sharing: NO. Countries: 1. Publications: 1.
Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT02227641. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma
ClinicalTrials.gov study NCT00901147. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00322985. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children with Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)
ClinicalTrials.gov study NCT05681260. IPD Sharing: Not stated. Countries: 1. Publications: 18.
Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
ClinicalTrials.gov study NCT00085930. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma
ClinicalTrials.gov study NCT01590732. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
ClinicalTrials.gov study NCT00000756. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT00136565. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-host-Disease
ClinicalTrials.gov study NCT03683498. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
ClinicalTrials.gov study NCT05996185. IPD Sharing: Not stated. Countries: 1. Publications: 19.
Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) Patients
ClinicalTrials.gov study NCT01036399. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer
ClinicalTrials.gov study NCT06139406. IPD Sharing: YES. Countries: 4. Publications: 0.
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT04726215. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.